Feedback / Questions
Carvykti (ciltacabtagene autoleucel) - J&J
Carvykti: Expiry of patents in US related to composition-of-matter in 2036
(J&J)
-
Jul 16, 2025 -
Q2 2025 Results
Patent
•
Hematological Malignancies • Multiple Myeloma • Oncology
https://s203.q4cdn.com/636242992/files/pipeline-tables/2025/03/2025-Information-About-our-Innovative-Medicine-Patent-Portfolio-for-release-v2.pdf
Jul 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious